Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly FCF Margin came in at 26.55% in Q4 2025, up 467.0% year-on-year from 4.68% in Q4 2024, and up 31.41% quarter-over-quarter from 20.2% in Q3 2025.
Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's FCF Margin history runs 16 years deep, the most recent figure standing at 26.55% for Q4 2025.
- On a quarterly basis, FCF Margin rose 467.0% year-over-year to 26.55% in Q4 2025; TTM through Dec 2025 was 24.21%, a 197.0% increase from a year earlier, with the FY2025 full-year figure at 21.38%, up 11.0% from the prior year.
- FCF Margin climbed to 26.55% in Q4 2025 per PBH's latest filing, from 20.2% in the prior quarter.
- Across five years, FCF Margin topped out at 31.33% in Q2 2025 and bottomed at 16.69% in Q2 2023.
- The 5-year median for FCF Margin is 21.52% (2024), against an average of 22.12%.
- Across the five-year window, FCF Margin sank 646 bps in 2021 and soared 1126 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 23.34% in 2021, then fell by 17 bps to 19.29% in 2022, then climbed by 27 bps to 24.57% in 2023, then decreased by 11 bps to 21.88% in 2024, then gained by 21 bps to 26.55% in 2025.
- Per Business Quant, the three latest PBH FCF Margin figures stand at 26.55% (Q4 2025), 20.2% (Q3 2025), and 31.33% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 26.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 20.20% |
| Jun 30, 2025 | 31.33% |
| Mar 31, 2025 | 19.68% |
| Dec 31, 2024 | 21.88% |
| Sep 30, 2024 | 23.88% |
| Jun 30, 2024 | 20.07% |
| Mar 31, 2024 | 23.02% |
| Dec 31, 2023 | 24.57% |
| Sep 30, 2023 | 20.79% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | 19.74% |
| Dec 31, 2022 | 19.29% |
| Sep 30, 2022 | 19.07% |
| Jun 30, 2022 | 20.65% |
| Mar 31, 2022 | 22.46% |
| Dec 31, 2021 | 23.34% |
| Sep 30, 2021 | 21.16% |
| Jun 30, 2021 | 25.19% |
| Mar 31, 2021 | 22.79% |